Mechanisms preventing allergen-induced airways hyperreactivity: Role of tolerance and immune deviation

Journal of Allergy and Clinical Immunology

Volumn 106, Issue 2, 2000, Pages 239-246

  Tsitoura, Daphne C ^a   Blumenthal, Robin L ^a   Berry, Gerald ^b   DeKruyff, Rosemarie H ^a   Umetsu, Dale T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Airway hyperreactivity; Allergy; Immune deviation; T lymphocytes; Tolerance

Indexed keywords

ALLERGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; OVALBUMIN;

ARTICLE; ASTHMA; ATOPY; BRONCHUS HYPERREACTIVITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033845105     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.108429     Document Type: Article

References (38)

1. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status
2. + T lymphocytes in atopic patients
3. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma
4. Asthma
5. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
6. Role of type 1 and type 2 T helper cells in allergic diseases
7. Lymphokine production by human T cells in disease states
8. + T cells from allergic individuals
9. Regulation of disease susceptibility: Decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis
10. The inverse association between tuberculin responses and atopic disorder
11. + T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production
12. Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells
13. Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma
14. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation
15. + T cells and IL- 18
16. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production
17. Heat-killed Listeria monocytogenes as an adjuvant converts established murine Th2-dominated immune responses into Th1-dominated responses
18. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgGl in mice
19. Role of cytokines in determining T-lymphocyte function
20. Immunoprophylaxis of atopy: Light at the end of the tunnel?
21. + T cells precedes the development of tolerance in vivo
22. + T cells
23. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: Influence of MHC binding affinity
24. + T cells or interferon (IFN)-gamma in a murine model of allergen sensitization
25. TGF-beta induced by oral tolerance ameliorates experimental tracheal eosinophilia
26. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases
27. A novel T cell-regulated mechanism modulating allergen-induced aiways hyperreactivity in BALB/c mice independently of IL-4 and IL-5
28. Interleukin 4, but not interleukin 5 or cosinophils, is required in a murine model of acute airway hyperreactivity
29. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice
30. Induction of airway mucus production By T helper 2 (Th2) cells: A critical role for interleukin 4 in cell recruitment but not mucus production
31. Th2-induced eotaxin expression and eosinophilia coexist with Th1 responses at the effector stage of lung inflammation
32. Modulation of airway inflammation by passive transfer of allergen- Specific Th1 and Th2 cells in a mouse model of asthma
33. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization
34. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis
35. Immunologic changes associated with allergen immunothempy
36. Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy
37. Successful immunotberapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom
38. Immunotherapy of allergy: Anergy, deletion, and immune deviation